SCHEMBL14302277

SCHEMBL14302277

C=C[C@@H]1C[C@]1(CC)C(=O)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STS P08842 1/20 0.41
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ MMP1 P03956 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ HPGD P15428 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ P4HTM Q9NXG6 1/20 0.36
▸ KDM1A O60341 2/20 0.36
▸ PKM P14618 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14278019 0.83 CA1 (0.41) STSCA1CA2MMP1MMP2
SCHEMBL14278305 0.80 ALDH1A1 (0.39) STSCA1CA2MMP1MMP2
SCHEMBL14364366 0.80 STS (0.45) STSCA1CA2MMP1MMP2
SCHEMBL14302082 0.77 METAP2 (0.34) CA1CA2ALDH1A1HSD17B10GAA
SCHEMBL14302279 0.76 HTR6 (0.35) CA1CA2
SCHEMBL14301679 0.76 POLB (0.44) MEN1KMT2A
SCHEMBL14302275 0.73 NLRP3 (0.40) ALDH1A1HSD17B10MAPTKDM4ESLC1A3
SCHEMBL11071481 0.72 AKT1 (0.37) HPGDALDH1A1MEN1KMT2AGAA
SCHEMBL14302071 0.71 MEN1 (0.48) HPGDALDH1A1MEN1KMT2AKDM4E
SCHEMBL14302072 0.70 ALDH1A1 (0.46) HPGDALDH1A1NPSR1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045530-A1 Organic Compounds and Their Uses BRANDL TRIXI 2008-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045530-A1 Organic Compounds and Their Uses OAT, OTC, AOX1 STS 1434/4885CA1 2516/4885CA2 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback